Atlas Trials

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)

Clinical trial NCT01202058 · TERMINATED

Trial details

NCT number
NCT01202058
Sponsor
Cordis US Corp.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Atherosclerotic Coronary Artery Disease
Start date
2010-08-01
Primary completion
2011-11-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.